GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 136 filers reported holding GENOMIC HEALTH INC in Q4 2017. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $401,000 | -24.3% | 6,897 | -8.9% | 0.07% | -21.4% |
Q1 2019 | $530,000 | +8.2% | 7,573 | -0.4% | 0.08% | -3.4% |
Q4 2018 | $490,000 | -48.0% | 7,605 | -43.3% | 0.09% | -34.1% |
Q3 2018 | $942,000 | +47.2% | 13,408 | -32.8% | 0.13% | +37.5% |
Q3 2017 | $640,000 | – | 19,947 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |